Stjepanovic MI et al. |
Pulmonary and Vertebral Mycobacterium avium Disease in a HIV-negative 71-year-old Man - A Case Report. |
2016 |
Infez Med |
pmid:28011973
|
Muñoz-Egea MC et al. |
Effect of Antibiotics and Antibiofilm Agents in the Ultrastructure and Development of Biofilms Developed by Nonpigmented Rapidly Growing Mycobacteria. |
2016 |
Microb. Drug Resist. |
pmid:26208145
|
Salimi A et al. |
Toxicity of macrolide antibiotics on isolated heart mitochondria: a justification for their cardiotoxic adverse effect. |
2016 |
Xenobiotica |
pmid:26068526
|
Miftahussurur M et al. |
Emerging Helicobacter pylori levofloxacin resistance and novel genetic mutation in Nepal. |
2016 |
BMC Microbiol. |
pmid:27809767
|
Losurdo G et al. |
Role of concomitant therapy for eradication: A technical note. |
2016 |
World J. Gastroenterol. |
pmid:27784977
|
Zycinska K et al. |
Antibiotic Treatment of Hospitalized Patients with Pneumonia Complicated by Clostridium Difficile Infection. |
2016 |
Adv. Exp. Med. Biol. |
pmid:27620311
|
Bax HI et al. |
Tigecycline Potentiates Clarithromycin Activity against Mycobacterium avium In Vitro. |
2016 |
Antimicrob. Agents Chemother. |
pmid:26883697
|
Hirata Y et al. |
Efficacy of triple therapy with esomeprazole, amoxicillin, and sitafloxacin as a third-line Helicobacter pylori eradication regimen. |
2016 |
Int. J. Infect. Dis. |
pmid:27590563
|
Liou JM et al. |
Concomitant, bismuth quadruple, and 14-day triple therapy in the first-line treatment of Helicobacter pylori: a multicentre, open-label, randomised trial. |
2016 |
Lancet |
pmid:27769562
|
Campillo A et al. |
[10-day triple therapy with esomeprazole 40 mg/12 h vs. quadruple concomitant non-bismuth therapy as first line treatment for Helicobacter pylori infection]. |
2016 |
Gastroenterol Hepatol |
pmid:27084668
|
Chauffour A et al. |
Sterilizing Activity of Fully Oral Intermittent Regimens against Mycobacterium Ulcerans Infection in Mice. |
2016 |
PLoS Negl Trop Dis |
pmid:27755552
|
Abuhammour A et al. |
Standard triple therapy versus sequential therapy for eradication of Helicobacter pylori in treatment naïve and retreat patients. |
2016 |
Arab J Gastroenterol |
pmid:27665525
|
Matsumoto H et al. |
Helicobacter pylori Eradication with Proton Pump Inhibitors or Potassium-Competitive Acid Blockers: The Effect of Clarithromycin Resistance. |
2016 |
Dig. Dis. Sci. |
pmid:27659671
|
Gisbert JP |
Helicobacter pylori-related diseases. |
2016 |
Gastroenterol Hepatol |
pmid:27888863
|
Zhou L et al. |
Tailored versus Triple plus Bismuth or Concomitant Therapy as Initial Helicobacter pylori Treatment: A Randomized Trial. |
2016 |
Helicobacter |
pmid:26104022
|
Rossi A et al. |
Floating modular drug delivery systems with buoyancy independent of release mechanisms to sustain amoxicillin and clarithromycin intra-gastric concentrations. |
2016 |
Drug Dev Ind Pharm |
pmid:26065531
|
Huh CW et al. |
Early Attempts to Eradicate Helicobacter pylori after Endoscopic Resection of Gastric Neoplasm Significantly Improve Eradication Success Rates. |
2016 |
PLoS ONE |
pmid:27588679
|
Watanabe M et al. |
Saturated fatty acids and fatty acid esters promote the polymorphic transition of clarithromycin metastable form I crystal. |
2016 |
Int J Pharm |
pmid:27553780
|
Nagashima A et al. |
Clarithromycin Suppresses Chloride Channel Accessory 1 and Inhibits Interleukin-13-Induced Goblet Cell Hyperplasia in Human Bronchial Epithelial Cells. |
2016 |
Antimicrob. Agents Chemother. |
pmid:27550358
|
Couture G et al. |
[Second case of serum sickness-like reaction to claritrhomycin]. |
2016 |
Presse Med |
pmid:27542759
|
Bugli F et al. |
In vitro effect of clarithromycin and alginate lyase against helicobacter pylori biofilm. |
2016 |
Biotechnol. Prog. |
pmid:27535356
|
Shichijo S et al. |
Vonoprazan versus conventional proton pump inhibitor-based triple therapy as first-line treatment against Helicobacter pylori: A multicenter retrospective study in clinical practice. |
2016 |
J Dig Dis |
pmid:27534444
|
Morimoto K et al. |
Macrolide-Resistant Mycobacterium avium Complex Lung Disease: Analysis of 102 Consecutive Cases. |
2016 |
Ann Am Thorac Soc |
pmid:27513168
|
Christianson S et al. |
Time-to-Detection of Inducible Macrolide Resistance in Mycobacterium abscessus Subspecies and Its Association with the Erm(41) Sequevar. |
2016 |
PLoS ONE |
pmid:27490181
|
Harada T et al. |
Premedication with Clarithromycin Is Effective against Secondary Bacterial Pneumonia during Influenza Virus Infection in a Pulmonary Emphysema Mouse Model. |
2016 |
J. Pharmacol. Exp. Ther. |
pmid:27489022
|
Bonfigli AR et al. |
Randomized, double-blind, placebo-controlled trial to evaluate the effect of Helicobacter pylori eradication on glucose homeostasis in type 2 diabetic patients. |
2016 |
Nutr Metab Cardiovasc Dis |
pmid:27480449
|
Orrin E et al. |
Sporotrichoid Mycobacterium chelonae. |
2016 |
Australas. J. Dermatol. |
pmid:27469486
|
Yamamoto K et al. |
Clarithromycin prevents human respiratory syncytial virus-induced airway epithelial responses by modulating activation of interferon regulatory factor-3. |
2016 |
Pharmacol. Res. |
pmid:27468646
|
Ferro BE et al. |
Failure of the Amikacin, Cefoxitin, and Clarithromycin Combination Regimen for Treating Pulmonary Mycobacterium abscessus Infection. |
2016 |
Antimicrob. Agents Chemother. |
pmid:27458221
|
Lotfipour F et al. |
Study of Antimicrobial Effects of Clarithromycin Loaded PLGA Nanoparticles against Clinical Strains of Helicobacter pylori. |
2016 |
Drug Res (Stuttg) |
pmid:25919643
|
Büchsel M et al. |
A case of septic arthritis caused by a Mycoplasma salivarium strain resistant towards Ciprofloxacin and Clarithromycin in a patient with chronic lymphatic leukemia. |
2016 |
Diagn. Microbiol. Infect. Dis. |
pmid:27342785
|
Lin LC et al. |
Nonbismuth concomitant quadruple therapy for Helicobacter pylori eradication in Chinese regions: A meta-analysis of randomized controlled trials. |
2016 |
World J. Gastroenterol. |
pmid:27340362
|
Abd-Elsalam S et al. |
A 2-week Nitazoxanide-based quadruple treatment as a rescue therapy for Helicobacter pylori eradication: A single center experience. |
2016 |
Medicine (Baltimore) |
pmid:27310977
|
De Francesco V et al. |
Two-week Triple Therapy with either Standard or High-dose Esomeprazole for First-line H. pylori Eradication. |
2016 |
J Gastrointestin Liver Dis |
pmid:27308644
|
Miyaki A et al. |
An assessment of the efficacy of first-line Helicobacter pylori-eradication therapy based on clarithromycin susceptibility. |
2016 |
Minerva Gastroenterol Dietol |
pmid:27304198
|
Okano Y et al. |
Miliary pulmonary nodules due to Mycobacterium xenopi in a steroid-induced immunocompromised patient successfully treated with chemotherapy: a case report. |
2016 |
BMC Pulm Med |
pmid:27287608
|
Steurer J |
[Months of antibiotic therapy in persistent symptoms of Lyme disease without effect]. |
2016 |
Praxis (Bern 1994) |
pmid:27269781
|
Chung JW et al. |
Ten-day empirical sequential or concomitant therapy is more effective than triple therapy for Helicobacter pylori eradication: A multicenter, prospective study. |
2016 |
Dig Liver Dis |
pmid:27257049
|
Mitchell H and Katelaris P |
Epidemiology, clinical impacts and current clinical management of Helicobacter pylori infection. |
2016 |
Med. J. Aust. |
pmid:27256648
|
Ullah S et al. |
Development of a biocompatible creatinine-based niosomal delivery system for enhanced oral bioavailability of clarithromycin. |
2016 |
Drug Deliv |
pmid:27247018
|
Kuo CH et al. |
A Rapid and Accurate Method to Evaluate Helicobacter pylori Infection, Clarithromycin Resistance, and CYP2C19 Genotypes Simultaneously From Gastric Juice. |
2016 |
Medicine (Baltimore) |
pmid:27227911
|
Sluch IM et al. |
Mycobacterium chelonae Scleral Abscess After Intravitreal Ranibizumab Injection. |
2016 |
Cornea |
pmid:27227391
|
Parize P et al. |
Induction therapy with linezolid/clarithromycin combination for Mycobacterium chelonae skin infections in immunocompromised hosts. |
2016 |
J Eur Acad Dermatol Venereol |
pmid:25677464
|
Xu J et al. |
Preparation, characterization and pharmacokinetics evaluation of clarithromycin-loaded Eudragit(®) L-100 microspheres. |
2016 |
Eur J Drug Metab Pharmacokinet |
pmid:25652786
|
Akram FE et al. |
A combination of silver nanoparticles and visible blue light enhances the antibacterial efficacy of ineffective antibiotics against methicillin-resistant Staphylococcus aureus (MRSA). |
2016 |
Ann. Clin. Microbiol. Antimicrob. |
pmid:27530257
|
Zollner-Schwetz I et al. |
Primary resistance of Helicobacter pylori is still low in Southern Austria. |
2016 |
Int. J. Med. Microbiol. |
pmid:27134190
|
Georgopoulos SD et al. |
Randomized clinical trial comparing ten day concomitant and sequential therapies for Helicobacter pylori eradication in a high clarithromycin resistance area. |
2016 |
Eur. J. Intern. Med. |
pmid:27134145
|
Kim JS et al. |
Sequential Therapy versus Triple Therapy for the First Line Treatment of Helicobacter pylori in Korea: A Nationwide Randomized Trial. |
2016 |
Gut Liver |
pmid:27114421
|
Manniello MD et al. |
Aerodynamic properties, solubility and in vitro antibacterial efficacy of dry powders prepared by spray drying: Clarithromycin versus its hydrochloride salt. |
2016 |
Eur J Pharm Biopharm |
pmid:27106605
|
Fallone CA et al. |
The Toronto Consensus for the Treatment of Helicobacter pylori Infection in Adults. |
2016 |
Gastroenterology |
pmid:27102658
|
Bilgilier C et al. |
Prevalence of clarithromycin-resistant Helicobacter pylori strains in gastric mucosa-associated lymphoid tissue lymphoma patients. |
2016 |
Ann. Hematol. |
pmid:27091350
|
Root AA et al. |
Evaluation of the risk of cardiovascular events with clarithromycin using both propensity score and self-controlled study designs. |
2016 |
Br J Clin Pharmacol |
pmid:27090996
|
Kazama I et al. |
Clarithromycin Dose-Dependently Stabilizes Rat Peritoneal Mast Cells. |
2016 |
Chemotherapy |
pmid:27088971
|
Huynh VA et al. |
[Fixed drug eruption to clarithromycin: The importance of challenge tests in diagnosis]. |
2016 |
Ann Dermatol Venereol |
pmid:27080820
|
EmiralioÄŸlu N et al. |
Pulmonary Mycobacterium abscessus Infection in a Patient with Triple A Syndrome. |
2016 |
J. Trop. Pediatr. |
pmid:27080471
|
Graham DY and Dore MP |
Helicobacter pylori therapy: a paradigm shift. |
2016 |
Expert Rev Anti Infect Ther |
pmid:27077447
|
Song ZQ et al. |
Hybrid Therapy Regimen for Helicobacter Pylori Eradication. |
2016 |
Chin. Med. J. |
pmid:27064046
|
Matsumoto H et al. |
Molecular Detection of H. pylori Using Adherent Gastric Mucous to Biopsy Forceps. |
2016 |
Helicobacter |
pmid:27061611
|
Tsaganos T et al. |
Clarithromycin Leads to Long-Term Survival and Cost Benefit in Ventilator-Associated Pneumonia and Sepsis. |
2016 |
Antimicrob. Agents Chemother. |
pmid:27044546
|
Buchicchio A et al. |
Biodegradation of carbamazepine and clarithromycin by Trichoderma harzianum and Pleurotus ostreatus investigated by liquid chromatography - high-resolution tandem mass spectrometry (FTICR MS-IRMPD). |
2016 |
Sci. Total Environ. |
pmid:27039063
|
Melia MT and Auwaerter PG |
Time for a Different Approach to Lyme Disease and Long-Term Symptoms. |
2016 |
N. Engl. J. Med. |
pmid:27028918
|
Berende A et al. |
Randomized Trial of Longer-Term Therapy for Symptoms Attributed to Lyme Disease. |
2016 |
N. Engl. J. Med. |
pmid:27028911
|
Seyama S et al. |
Clarithromycin Resistance Mechanisms of Epidemic β-Lactamase-Nonproducing Ampicillin-Resistant Haemophilus influenzae Strains in Japan. |
2016 |
Antimicrob. Agents Chemother. |
pmid:26953210
|
Ji Z et al. |
The Association of Age and Antibiotic Resistance of Helicobacter Pylori: A Study in Jiaxing City, Zhejiang Province, China. |
2016 |
Medicine (Baltimore) |
pmid:26937912
|
Murakami K et al. |
Vonoprazan, a novel potassium-competitive acid blocker, as a component of first-line and second-line triple therapy for Helicobacter pylori eradication: a phase III, randomised, double-blind study. |
2016 |
Gut |
pmid:26935876
|
Park JY et al. |
Helicobacter pylori Clarithromycin Resistance and Treatment Failure Are Common in the USA. |
2016 |
Dig. Dis. Sci. |
pmid:26923948
|
Guirao-Arrabal E et al. |
Clarithromycin plus linezolid as a sequential therapy for implantable-cardioverter-defibrillator infection caused by coagulase-negative staphylococci. |
2016 |
Rev Esp Quimioter |
pmid:26888341
|
Friedman ND et al. |
Increasing Experience with Primary Oral Medical Therapy for Mycobacterium ulcerans Disease in an Australian Cohort. |
2016 |
Antimicrob. Agents Chemother. |
pmid:26883709
|
Chua CS et al. |
The efficacy of blueberry and grape seed extract combination on triple therapy for Helicobacter pylori eradication: a randomised controlled trial. |
2016 |
Int J Food Sci Nutr |
pmid:26883189
|
Meng X et al. |
[Antibiotic resistance of Helicobacter pylori clinical isolates in Hebei Province]. |
2016 |
Zhonghua Yi Xue Za Zhi |
pmid:26879786
|
Bakshi SS |
Outcome evaluation of clarithromycin, metronidazole and lansoprazole regimens in Helicobacter pylori positive or negative children with resistant otitis media with effusion. |
2016 |
J Laryngol Otol |
pmid:26878377
|
Franceschi F et al. |
High dose amoxicillin-based first line regimen is equivalent to sequential therapy in the eradication of H. pylori infection. |
2016 |
Eur Rev Med Pharmacol Sci |
pmid:26875899
|
Tepeš B et al. |
Randomized clinical trial comparing 10-day sequential, 7-day concomitant and 7-day standard triple therapies for Helicobacter pylori eradication. |
2016 |
Eur J Gastroenterol Hepatol |
pmid:26862930
|
Lim SG et al. |
The relationship between the failure to eradicate Helicobacter pylori and previous antibiotics use. |
2016 |
Dig Liver Dis |
pmid:26856963
|
Trac MH et al. |
Macrolide antibiotics and the risk of ventricular arrhythmia in older adults. |
2016 |
CMAJ |
pmid:26903359
|
Niv Y |
Doxycycline in Eradication Therapy of Helicobacter pylori--a Systematic Review and Meta-Analysis. |
2016 |
Digestion |
pmid:26849820
|
Song Z et al. |
Levofloxacin, bismuth, amoxicillin and esomeprazole as second-line Helicobacter pylori therapy after failure of non-bismuth quadruple therapy. |
2016 |
Dig Liver Dis |
pmid:26847964
|
Mukai S et al. |
Macrolides sensitize EGFR-TKI-induced non-apoptotic cell death via blocking autophagy flux in pancreatic cancer cell lines. |
2016 |
Int. J. Oncol. |
pmid:26718641
|
Iyer G and Alexander GC |
Cardiovascular risks associated with clarithromycin. |
2016 |
BMJ |
pmid:26769796
|
Wong AY et al. |
Cardiovascular outcomes associated with use of clarithromycin: population based study. |
2016 |
BMJ |
pmid:26768836
|
Hirama T et al. |
PCR-Based Rapid Identification System Using Bridged Nucleic Acids for Detection of Clarithromycin-Resistant Mycobacterium avium-M. intracellulare Complex Isolates. |
2016 |
J. Clin. Microbiol. |
pmid:26739154
|
Radheshi E et al. |
Postmortem diagnosis of anaphylaxis in presence of decompositional changes. |
2016 |
J Forensic Leg Med |
pmid:26735898
|
Hassan ST et al. |
In vitro synergistic effect of Hibiscus sabdariffa aqueous extract in combination with standard antibiotics against Helicobacter pylori clinical isolates. |
2016 |
Pharm Biol |
pmid:26731378
|
Çağan-Appak Y et al. |
Clarithromycin resistance and 23S rRNA gene point mutations of Helicobacter pylori infection in children. |
2016 |
Turk. J. Pediatr. |
pmid:28276208
|
Thung I et al. |
Review article: the global emergence of Helicobacter pylori antibiotic resistance. |
2016 |
Aliment. Pharmacol. Ther. |
pmid:26694080
|
Vermeer LM et al. |
Evaluation of Ketoconazole and Its Alternative Clinical CYP3A4/5 Inhibitors as Inhibitors of Drug Transporters: The In Vitro Effects of Ketoconazole, Ritonavir, Clarithromycin, and Itraconazole on 13 Clinically-Relevant Drug Transporters. |
2016 |
Drug Metab. Dispos. |
pmid:26668209
|
Meng Y et al. |
Multi-functional Liposomes Enhancing Target and Antibacterial Immunity for Antimicrobial and Anti-Biofilm Against Methicillin-Resistant Staphylococcus aureus. |
2016 |
Pharm. Res. |
pmid:26666773
|
Konstantinidis T et al. |
Immunomodulatory Role of Clarithromycin in Acinetobacter baumannii Infection via Formation of Neutrophil Extracellular Traps. |
2016 |
Antimicrob. Agents Chemother. |
pmid:26643338
|
Wu TS et al. |
Postcesarean section wound infection caused by Mycobacterium massiliense. |
2016 |
J Microbiol Immunol Infect |
pmid:26350122
|
Kamiya K et al. |
Erythema multiforme caused by triple therapy with amoxicillin, clarithromycin and vonoprazan for Helicobacter pylori. |
2016 |
J. Dermatol. |
pmid:26508502
|
Mark TM and Coleman M |
It's Time to Take Clarithromycin Seriously in Multiple Myeloma. |
2016 |
Acta Haematol. |
pmid:26505907
|
Qiu XH et al. |
Clarithromycin Synergistically Enhances Thalidomide Cytotoxicity in Myeloma Cells. |
2016 |
Acta Haematol. |
pmid:26505646
|
Senatore FJ et al. |
Helicobacter pylori treatment: Still a work in progress. |
2016 |
Postgrad Med |
pmid:26490697
|
Apostolopoulos P et al. |
Concomitant versus sequential therapy for the treatment of Helicobacter pylori infection: a Greek randomized prospective study. |
2016 |
Scand. J. Gastroenterol. |
pmid:26435055
|
Narita M et al. |
Antimicrobial Susceptibility of Microorganisms Isolated from Periapical Periodontitis Lesions. |
2016 |
Bull. Tokyo Dent. Coll. |
pmid:27665691
|
Hollitt A et al. |
Cat scratch disease of the parotid gland. |
2016 |
Arch. Dis. Child. |
pmid:26403943
|
Oh B et al. |
The Effect of Probiotics on Gut Microbiota during the Helicobacter pylori Eradication: Randomized Controlled Trial. |
2016 |
Helicobacter |
pmid:26395781
|
Lee J et al. |
A new anti-microbial combination prolongs the latency period, reduces acute histologic chorioamnionitis as well as funisitis, and improves neonatal outcomes in preterm PROM. |
2016 |
J. Matern. Fetal. Neonatal. Med. |
pmid:26373262
|
Ghaith D et al. |
Mutations affecting domain V of the 23S rRNA gene in Helicobacter pylori from Cairo, Egypt. |
2016 |
J Chemother |
pmid:26358218
|
Tsujimae M et al. |
A Comparative Study of a New Class of Gastric Acid Suppressant Agent Named Vonoparazan versus Esomeprazole for the Eradication of Helicobacter pylori. |
2016 |
Digestion |
pmid:28030862
|